MediWound Ltd. (MDWD) stock
MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$13.61−0.07 (-0.51%)
Close on Nov 18, 2026Market cap $174.69MP/E –Yield –
MediWound operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$25.27M. The highest annual figure on record is $4.49M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$25.27M | – |
| FY2024 | Dec 31, 2024 | -$19.40M | – |
| FY2023 | Dec 31, 2023 | -$15.29M | – |
| FY2022 | Dec 31, 2022 | -$8.35M | – |
| FY2021 | Dec 31, 2021 | -$11.22M | – |
| FY2020 | Dec 31, 2020 | -$8.84M | -296.8% |
| FY2019 | Dec 31, 2019 | $4.49M | – |
| FY2018 | Dec 31, 2018 | -$3.96M | – |
| FY2017 | Dec 31, 2017 | -$13.69M | – |
| FY2016 | Dec 31, 2016 | -$20.16M | – |
| FY2015 | Dec 31, 2015 | -$21.23M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.46M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.72M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.48M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.01M | -128.7% |
| Q2 FY2022 | Jun 30, 2022 | -$3.67M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.90M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.71M | – |
| Q2 FY2019 | Jun 30, 2019 | $13.94M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.29M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.70M | – |
See a number that looks wrong?